Study on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung Cancer

PHASE4RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 15, 2024

Primary Completion Date

September 15, 2025

Study Completion Date

September 15, 2028

Conditions

Small Cell Lung Cancer

Interventions

DRUG

Irinotecan hydrochloride liposome injection

Irinotecan hydrochloride liposome injection combined with platinum

Trial Locations (1)

RECRUITING

Tangdu Hospital, Xi'an

All Listed Sponsors

lead

Tang-Du Hospital

OTHER